This study is vital as around 38% of adults and 13% of children/adolescents globally have fatty liver disease. In this study, the panel was unanimous in their agreement prioritising improved research into validating non-invasive testing methods, as well as other early diagnosis, prognosis and disease-monitoring techniques. The potential for use of digital technologies within this sector was also agreed upon. Furthermore, multidisciplinary, multi-pronged methods of addressing risk factors for fatty liver disease was agreed upon, including social, environmental and genetic. Furthermore, they agreed that patient and community engagement is important. This review by Lazarus JV et al. aimed to discuss the global priorities on researching, preventing and treating fatty liver disease.
Overall, this panel agreed that the public health system must prioritise research into treatment, managing and treating fatty liver disease. They highlighted the need for collective and collaborative thinking and action on the matter to improve outcomes.